SCHEMBL6987628

SCHEMBL6987628

CS(=O)(=O)N(Cc1ccccc1)c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C#N)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 4/20 0.48
ALDH1A1 P00352 5/20 0.45
HPGD P15428 3/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
LMNA P02545 1/20 0.44
TP53 P04637 2/20 0.42
RORC P51449 1/20 0.41
USP2 O75604 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
AR P10275 1/20 0.40
PARP1 P09874 1/20 0.40
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985998 0.88 NR3C1 (0.47) NR3C1ALDH1A1HPGDMEN1KMT2A
SCHEMBL6986006 0.87 NR3C1 (0.46) NR3C1ALDH1A1HPGDMEN1KMT2A
Hydrochloric Acid SCHEMBL6984240 0.86 F10 (0.47) NR3C1ALDH1A1HPGDMEN1KMT2A
SCHEMBL6980127 0.86 NR3C1 (0.53) NR3C1ALDH1A1HPGDMEN1KMT2A
SCHEMBL6979167 0.84 KDM1A (0.47) NR3C1ALDH1A1HPGDMEN1KMT2A
SCHEMBL6977634 0.84 NR3C1 (0.53) NR3C1ALDH1A1HPGDMEN1KMT2A
SCHEMBL6987632 0.84 ALDH1A1 (0.39) NR3C1ALDH1A1HPGDMEN1KMT2A
SCHEMBL6981593 0.83 LTB4R2 (0.52) NR3C1ALDH1A1HPGDMEN1KMT2A
SCHEMBL6984164 0.82 KDM1A (0.43) NR3C1ALDH1A1HPGDMEN1KMT2A
SCHEMBL7956609 0.82 NR3C1 (0.44) NR3C1ALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed